retatrutide parkinson's disease trial Results: 28.3% Weight Loss Data 💉𝗥𝗲𝘁𝗮𝘁𝗿𝘂𝘁𝗶𝗱𝗲'𝘀 𝗨𝗻𝗲𝘅𝗽𝗲𝗰𝘁𝗲𝗱 𝗦𝗶𝗱𝗲 𝗘𝗳𝗳𝗲𝗰𝘁: 𝗪𝗵𝗮𝘁

Novo Nordisk A/S: Oral semaglutide 50 mg achieved 15.1% weight loss (17.4% if all people adhered to treatment) in adults with obesity or overweight in the OASIS 1 trial

Coindre JM, Terrier P, Guillou L, Le Doussal V, Collin F, Ranchre D, et al

Join 350,000+ subscribers and keep yourself informed with a selection of The Weeks most interesting, enlightening and entertaining stories - plus daily puzzles

Compounded GLP-1s are often much cheaper than name brand medications and more accessible during a shortage

Drug manufacturers sometimes offer patient assistance programs and savings cards that can help offset the costs of these medications